Tag: Cancer Drugs

Keytruda Received Another FDA Approval

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, for the adjuvant treatment ...

Priority Review for Personilized Med of Genentech

Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Applications (NDAs) and granted Priority Review for entrectinib f...

Launch of Company Focusing on Preventing Cancer Metastasis

HiberCell, a biotechnology company developing therapeutics focused on preventing cancer relapse and metastasis, launched on February 8 with $60.75M in Series A funding led by ARCH Venture Partners. Hi...

Russian Scientists Developed Cancer Drug

Russian scientists have developed a new drug for the treatment of cancer, which is comparable to the drug whose creators were awarded the Nobel Prize last year, and its certification is expected to ta...

EC Approved Clovis Drug for Relapsed Ovarian Cancer

Clovis Oncology has secured approval from the European Commission (EC) for its Rubraca (rucaparib) as maintenance treatment for women with relapsed ovarian cancer. The second indication of Rubraca ...

Expanded Indication from EC for Amgen’s Drug

Amgen announced that the European Commission (EC) has approved an expanded indication for BLINCYTO (blinatumomab) monotherapy to include adult patients with Philadelphia chromosome negative (Ph-) CD19...

Redx to Restart Cancer Drug Trial

Redx has secured approval from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to restart a phase 1/2a trial for its cancer candidate RXC004 in advanced solid tumors. An oral po...

US Tries First Digital Oncology Drugs

Cancer patients in the US are trialling digital oncology drugs for the first time, collecting data on patients in a bid to improve outcomes and help adherence. The new technology from Proteus Digit...

Samsung Cancer Drug Approved by FDA

The US Food and Drug Administration (FDA) has granted approval for Samsung Bioepis to use Ontruzant (trastuzumab-dttb) to treat a range of cancers. Ontruzant, which will be marketed in the US by Me...

Lilly’s Cancer Drug Failed Trial

Shares in Eli Lilly were down in early trading after the US drugmaker said its cancer drug Lartruvo failed to meet main survival goals in a late stage trial, prompting the company to stop promoting th...

Acrotech to Acquire 7 FDA-Approved Spectrum’s Drugs

Aurobindo Pharma’s subsidiary Acrotech Biopharma has agreed to acquire seven FDA-approved hematology/oncology products from Spectrum Pharmaceuticals in a deal valued at around $300m. Under the deal...

Keytruda to Reduce Death Risk by 31%

Merck
Merck, known as MSD outside the United States and Canada, announced the first presentation of results from KEYNOTE-181, a Phase 3 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherap...

Successful Trial for UroGen’s Cancer Drug

Former Novartis oncology chief Liz Barrett’s decision to jump ship to lead the biotech UroGen appears to have been vindicated after the company announced top-line results showing its lead drug could c...

Liver Cancer Drug of Bayer has Final NICE Recommendation

bayer
Bayer’s Stivarga has received a final green light from the National Institute for Health and Care Excellence (NICE) for use by the NHS to treat advanced liver cancer. Stivarga (regorafenib) is reco...

Prophylactic Vaccines are Most Popular among Cancer Vaccines

Cancer vaccines are a type of immunotherapy used to either treat existing cancer or prevent the development of cancer. Cancer treatment vaccines, also called therapeutic vaccines, work to boost the...

GE Healthcare and VUMC to Develop New DIagnostic Tools for Cancer Treatment

New diagnostic tools will be developed by GE Healthcare and Vanderbilt University Medical Centre (VUMC) to help make cancer immunotherapies safer and more accurate. As part of a five-year partnersh...